Constitutive Active Mutant TIE2 Induces Enlarged Vascular Lumen Formation with Loss of Apico-basal Polarity and Pericyte Recruitment.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 08 2019
Historique:
received: 14 05 2019
accepted: 13 08 2019
entrez: 28 8 2019
pubmed: 28 8 2019
medline: 22 10 2020
Statut: epublish

Résumé

Abnormalities in controlling key aspects of angiogenesis including vascular cell migration, lumen formation and vessel maturation are hallmarks of vascular anomalies including venous malformation (VM). Gain-of-function mutations in the tyrosine kinase receptor TIE2 can cause VM and induce a ligand-independent hyperactivation of TIE2. Despite these important findings, the TIE2-dependent mechanisms triggering enlarged vascular lesions are not well understood. Herein we studied TIE2 p.L914F, the most frequent mutation identified in VM patients. We report that endothelial cells harboring a TIE2-L914F mutation display abnormal cell migration due to a loss of front-rear polarity as demonstrated by a non-polarized Golgi apparatus. Utilizing a three-dimensional fibrin-matrix based model we show that TIE2-L914F mutant cells form enlarged lumens mimicking vascular lesions present in VM patients, independently of exogenous growth factors. Moreover, these abnormal vascular channels demonstrate a dysregulated expression pattern of apico-basal polarity markers Podocalyxin and Collagen IV. Furthermore, in this system we recapitulated another pathological feature of VM, the paucity of pericytes around ectatic veins. The presented data emphasize the value of this in vitro model as a powerful tool for the discovery of cellular and molecular signals contributing to abnormal vascular development and subsequent identification of novel therapeutic approaches.

Identifiants

pubmed: 31451744
doi: 10.1038/s41598-019-48854-2
pii: 10.1038/s41598-019-48854-2
pmc: PMC6710257
doi:

Substances chimiques

Biomarkers 0
Receptor, TIE-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

12352

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL117952
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128584
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL136139
Pays : United States

Références

Nat Med. 2010 Apr;16(4):420-8
pubmed: 20364125
J Pathol. 2017 Jan;241(2):281-293
pubmed: 27859310
Cell Rep. 2018 Sep 11;24(11):2869-2882
pubmed: 30208313
Int J Dev Biol. 2011;55(4-5):353-63
pubmed: 21732275
Hum Mol Genet. 1999 Jul;8(7):1279-89
pubmed: 10369874
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):496-512
pubmed: 30626204
Angiogenesis. 2013 Jan;16(1):207-22
pubmed: 23086340
Cancer Res. 2015 Jan 1;75(1):40-50
pubmed: 25388284
Oncogene. 2008 Nov 24;27(55):6970-80
pubmed: 19029938
J Cell Biol. 1986 Feb;102(2):484-91
pubmed: 3511072
Cancer Cell. 2006 Aug;10(2):159-70
pubmed: 16904613
Annu Rev Pathol. 2007;2:251-75
pubmed: 18039100
J Cell Sci. 2010 Apr 1;123(Pt 7):1073-80
pubmed: 20332120
Cancer Res. 2004 Aug 1;64(15):5068-73
pubmed: 15289306
Eur J Hum Genet. 2010 Apr;18(4):414-20
pubmed: 19888299
J Cell Biol. 2008 Nov 17;183(4):625-33
pubmed: 19001128
Otolaryngol Clin North Am. 2018 Feb;51(1):41-53
pubmed: 29217067
Dev Cell. 2010 Jan 19;18(1):39-51
pubmed: 20152176
Nature. 2002 Dec 12;420(6916):629-35
pubmed: 12478284
PLoS One. 2017 Sep 14;12(9):e0184461
pubmed: 28910325
PLoS One. 2007 Feb 21;2(2):e237
pubmed: 17311105
Development. 2018 Jul 2;145(13):
pubmed: 29853619
Dev Cell. 2009 Oct;17(4):505-15
pubmed: 19853564
Exp Cell Res. 2013 May 15;319(9):1247-54
pubmed: 23567183
Birth Defects Res C Embryo Today. 2007 Dec;81(4):270-85
pubmed: 18228260
Sci Rep. 2014 Jun 26;4:5457
pubmed: 24966004
Curr Probl Surg. 2000 Aug;37(8):517-84
pubmed: 10955029
J Am Soc Nephrol. 2009 Aug;20(8):1669-76
pubmed: 19578008
Development. 1999 Jun;126(14):3047-55
pubmed: 10375497
Curr Biol. 2008 Apr 8;18(7):507-13
pubmed: 18394894
J Biol Chem. 1992 Jun 5;267(16):10931-4
pubmed: 1375931
J Cell Biol. 2001 Apr 30;153(3):543-53
pubmed: 11331305
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4518-4527
pubmed: 30787191
Hum Mol Genet. 2013 Sep 1;22(17):3438-48
pubmed: 23633549
Hum Mol Genet. 2011 Jan 15;20(2):211-22
pubmed: 20940147
Bio Protoc. 2016 Nov 5;6(21):
pubmed: 28573164
Angiogenesis. 2018 Nov;21(4):725-735
pubmed: 29786783
Science. 1997 Jul 11;277(5323):242-5
pubmed: 9211853
Hum Mol Genet. 2015 Nov 15;24(22):6374-89
pubmed: 26319232
Development. 2014 Nov;141(21):4121-6
pubmed: 25336741
Cell. 1996 Dec 27;87(7):1181-90
pubmed: 8980225
Blood. 2009 Dec 3;114(24):5091-101
pubmed: 19822899
Nat Genet. 2009 Jan;41(1):118-24
pubmed: 19079259
J Cell Biol. 1987 Sep;105(3):1455-62
pubmed: 3654761
Science. 2003 Dec 5;302(5651):1704-9
pubmed: 14657486
Proc Natl Acad Sci U S A. 1982 Apr;79(8):2603-7
pubmed: 7045867
Methods Enzymol. 2008;443:65-82
pubmed: 18772011
Blood. 2009 Jul 9;114(2):237-47
pubmed: 19339693
Microvasc Res. 2003 Sep;66(2):102-12
pubmed: 12935768
J Clin Invest. 2015 Sep;125(9):3491-504
pubmed: 26258417
Development. 1998 May;125(9):1591-8
pubmed: 9521897
Angiogenesis. 2018 May;21(2):363-380
pubmed: 29460088
Dev Cell. 2011 Apr 19;20(4):526-39
pubmed: 21396893
Nat Med. 2016 Sep;22(9):1033-1042
pubmed: 27548575
Cell. 1996 Dec 27;87(7):1153-5
pubmed: 8980221
Sci Transl Med. 2016 Mar 30;8(332):332ra42
pubmed: 27030594
Int J Pediatr. 2012;2012:645678
pubmed: 22611412
Am J Hum Genet. 2015 Dec 3;97(6):914-21
pubmed: 26637981
Genes Dev. 1994 Aug 15;8(16):1888-96
pubmed: 7958864
Nat Commun. 2016 Nov 29;7:13650
pubmed: 27897192
Physiol Rev. 2005 Jul;85(3):979-1000
pubmed: 15987800
Curr Opin Cell Biol. 2008 Apr;20(2):227-34
pubmed: 18282696

Auteurs

Yuqi Cai (Y)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Sandra Schrenk (S)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Jillian Goines (J)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

George E Davis (GE)

Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

Elisa Boscolo (E)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA. elisa.boscolo@cchmc.org.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. elisa.boscolo@cchmc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH